Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen

References

• Behl A, Nair A, Mohagaonkar S, Yadav P, Gambhir K, Tyagi N, Sharma RK, Butola BS, Sharma N. Threat, challenges, and preparedness for future pandemics: a descriptive review of phylogenetic analysis based predictions. Infect Genet Evol [Internet]. 2022;98:105217. [cited 2023 Dec 6]. Available from. https://pubmed.ncbi.nlm.nih.gov/35065303/.
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, ADME O, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med [Internet]. 2012;367(19):1814–14 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/23075143/.
   PubMed Web of Science ®Google Scholar
• Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The middle east respiratory syndrome (MERS). Infect Dis Clin North Am [Internet]. 2019;33(4):891–905 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/31668197/.
   PubMed Web of Science ®Google Scholar
• Ki M. MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health [Internet]. 2015;37:e2015033. [cited 2023 Dec 6]. Available from. https://pubmed.ncbi.nlm.nih.gov/26212508/.
   Google Scholar
• WHO. MERS SITUATION UPDATE February 2023 GLOBAL and REGIONAL CASES. 2023.
   Google Scholar
• Tai W, Zhang X, Yang Y, Zhu J, Du L. Advances in mRNA and other vaccines against MERS-CoV. Transl Res [Internet]. 2022;242:20–37. [cited 2023 Dec 6]. Available from. https://pubmed.ncbi.nlm.nih.gov/34801748/.
   PubMed Web of Science ®Google Scholar
• Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, Guo D, Fu L, Cui Y, Liu X. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res [Internet] [ Available from]. 2013;23(8):986–93. [cited 2023 Dec 6]. doi:10.1038/cr.2013.92.
   PubMed Web of Science ®Google Scholar
• Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S. MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets [Internet]. 2017;21(2):131–43 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/27936982/.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, Lu G, Wu Y, Yan J, Shi Y. et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun [Internet]. 2017;8(1): [cited 2023 Dec 6]. Available from. doi:10.1038/ncomms15092.
   Google Scholar
• Beniac DR, SL DV, Andonov A, He R, Booth TF. Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion. PLoS One [Internet]. 2007;2(10):e1082 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/17957264/.
   PubMed Web of Science ®Google Scholar
• Bosch BJ, van der Zee R, CAM DH, Rottier PJM. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol [Internet]. 2003;77(16):8801–11 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/12885899/.
   PubMed Web of Science ®Google Scholar
• Modjarrad K, Roberts CC, Mills KT, Castellano AR, Paolino K, Muthumani K, Reuschel EL, Robb ML, Racine T, Don OM. et al. Safety and immunogenicity of an anti-middle east respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Lancet Infect Dis [Internet]. 2019;19(9):1013–22. cited 2023 Dec 6. Available from. https://pubmed.ncbi.nlm.nih.gov/31351922/.
   PubMed Web of Science ®Google Scholar
• Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A. et al. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for middle east respiratory syndrome: an open-label, phase 1 trial. Lancet infect dis [internet]. 2020;20(7):827–38. cited 2023 Dec 6. Available from. https://pubmed.ncbi.nlm.nih.gov/32325037/.
   PubMed Web of Science ®Google Scholar
• Folegatti PM, Bittaye M, Flaxman A, Lopez FR, Bellamy D, Kupke A, Mair C, Makinson R, Sheridan J, Rohde C. et al. Safety and immunogenicity of a candidate middle east respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis [Internet]. 2020;20(7):816–26. cited 2023 Dec 6. Available from. https://pubmed.ncbi.nlm.nih.gov/32325038/.
   PubMed Web of Science ®Google Scholar
• Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, Tang H, Nishiura K, Peng J, Tan Z. et al.Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight [Internet]2019cited 2023 Dec 154 Available fromhttps://pmc/articles/PMC6478436/4
   Web of Science ®Google Scholar
• Zhou P, Li Z, Xie L, An D, Fan Y, Wang X, Li Y, Liu X, Wu J, Li G. et al. Research progress and challenges to coronavirus vaccine development. J Med Virol [Internet]. 2021;93(2):741–54. cited 2023 Dec 6. Available from. https://pubmed.ncbi.nlm.nih.gov/32936465/.
   PubMed Web of Science ®Google Scholar
• Bigay J, Le Grand R, Martinon F, Maisonnasse P. Vaccine-associated enhanced disease in humans and animal models: lessons and challenges for vaccine development. Front Microbiol [Internet] Available from. 2022;13 [cited 2023 Dec 6]. https://pubmed.ncbi.nlm.nih.gov/36033843/.
   PubMed Web of Science ®Google Scholar
• Chen Z, Bao L, Chen C, Zou T, Xue Y, Li F, Lv Q, Gu S, Gao X, Cui S. et al. Human neutralizing monoclonal antibody inhibition of middle east respiratory syndrome coronavirus replication in the common marmoset. J Infect Dis [internet]. 2017;215(12):1807–15. cited 2023 Dec 9. Available from. https://pubmed.ncbi.nlm.nih.gov/28472421/.
   PubMed Web of Science ®Google Scholar
• Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A [InternetAvailable from]. 2017;114(35):E7348–57. [cited 2023 Dec 6]. doi:10.1073/pnas.1707304114.
   PubMed Web of Science ®Google Scholar
• Çelik İ, Saatçi E, Eyüboğlu FÖ. Emerging and reemerging respiratory viral infections up to covid-19. Turkish J Med Sci [Internet]. 2020;50(SI–1):557–62 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/32293833/.
   PubMedGoogle Scholar
• Yang TJ, Yu PY, Chang YC, Hsu S Te D. D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation. J Biol Chem. 2021;297(4):101238 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/34563540/.
   PubMed Web of Science ®Google Scholar
• Joshi A, Akhtar N, Sharma NR, Kaushik V, Borkotoky S. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology. J Biomol Struct Dyn [Internet]. cited 2023 Dec 6]; Available from 2023;41(22):12464–79. doi:10.1080/07391102.2023.2191137.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zou H, Liu C, Zang M, Liu T. Combining deep neural networks for protein secondary structure prediction. IEEE Access. 2020;8:84362–70. doi:10.1109/ACCESS.2020.2992084.
   Web of Science ®Google Scholar
• Walls AC, Xiong X, Park YJ, Tortorici MA, Snijder J, Quispe J, Cameroni E, Gopal R, Dai M, Lanzavecchia A. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell [Internet] [ Available from]. 2019;176(5):1026–39.e15. [cited 2023 Dec 9]. doi:10.1016/j.cell.2018.12.028.
   Google Scholar
• Srivastava M, Mittal L, Kumari A, Agrahari AK, Singh M, Mathur R, Asthana S. Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint. Protein Sci [Internet] [ Available from]. 2022 [cited 2023 Dec 9];31(9). https://pubmed.ncbi.nlm.nih.gov/36629250/.
   Google Scholar
• Kumari A, Mittal L, Srivastava M, Pathak DP, Asthana S. Deciphering the structural determinants critical in attaining the FXR partial agonism. J Phys Chem B InternetAvailable from. 2023;127(2):465–85. [cited 2023 Dec 9]. doi:10.1021/acs.jpcb.2c06325.
   PubMed Web of Science ®Google Scholar
• Srivastava M, Mittal L, Sarmadhikari D, Singh VK, Fais A, Kumar A, Asthana S. Template entrance channel as possible allosteric inhibition and resistance site for quinolines tricyclic derivatives in RNA dependent RNA polymerase of bovine viral diarrhea virus. Pharmaceuticals (Basel) InternetAvailable from. 2023;16(3):376. [cited 2023 Dec 9]. doi:10.3390/ph16030376.
   PubMedGoogle Scholar
• Mittal L, Tonk RK, Awasthi A, Asthana S. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline. Comput Biol Chem [Internet]. 2023;107:107965. [cited 2023 Dec 9]. Available from. https://pubmed.ncbi.nlm.nih.gov/37826990/.
   Google Scholar
• Walls AC, Tortorici MA, Frenz B, Snijder J, Li W, Rey FA, DiMaio F, Bosch BJ, Veesler D. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat Struct Mol Biol [Internet] Available from. 2016;23(10):899–905. [cited 2023 Dec 6]. doi:10.1038/nsmb.3293.
   PubMed Web of Science ®Google Scholar
• Pandey VK, Sharma R, Prajapati GK, Mohanta TK, Mishra AK. N-glycosylation, a leading role in viral infection and immunity development. Mol Biol Rep [Internet] Available from. 2022;49(8):8109–20. [cited 2023 Dec 6]. doi:10.1007/s11033-022-07359-4.
   PubMed Web of Science ®Google Scholar
• Arruda HRS, Lima TM, Alvim RGF, Victorio FBA, Abreu DPB, Marsili FF, Cruz KD, Marques MA, Sosa-Acosta P, Quinones-Vega M. et al. Conformational stability of SARS-CoV-2 glycoprotein spike variants. iSci [ Available from]. 2023;26(1):105696. [cited 2024 Mar 18]. doi:10.1016/j.isci.2022.105696.
   PubMed Web of Science ®Google Scholar
• Hauser A, Carnell G, Held K, Sulbaran G, Tischbierek N, Rogers L, Pollakis G, Tonks P, Hoelscher M, Ding S. et al. Stepwise conformational stabilization of a HIV-1 clade C consensus envelope trimer immunogen impacts the profile of vaccine-induced antibody responses. Vaccines [Internet] [ Available from]. 2021;9(7):750. [cited 2024 Mar 18]. doi:10.3390/vaccines9070750.
   PubMed Web of Science ®Google Scholar
• Juraszek J, Rutten L, Blokland S, Bouchier P, Voorzaat R, Ritschel T, Bakkers MJG, Renault LLR. Langedijk JPMStabilizing the closed SARS-CoV-2 spike trimer. Nat Commun 2021 121 [Internet] Available from2021cited 2024 Mar 18121–8https://www.nature.com/articles/s41467-020-20321-x1
   Google Scholar
• Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther [Internet] [ Available from]. 2023 [cited 2023 Dec 6];8(1). https://pubmed.ncbi.nlm.nih.gov/37468460/.
   Google Scholar
• Akache B, Stark FC, Agbayani G, Renner TM, MJ M. Adjuvants: engineering protective immune responses in human and veterinary vaccines. Methods Mol Biol [Internet]. 2022;2412:179–231. [cited 2023 Dec 6]. Available from. https://pubmed.ncbi.nlm.nih.gov/34918246/.
   PubMedGoogle Scholar
• Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol [Internet] Available from. 2013;4 [cited 2023 Dec 6]. https://pubmed.ncbi.nlm.nih.gov/23720661/.
   PubMed Web of Science ®Google Scholar
• Perween R, PraveenKumar M, Shrivastava T, Parray HA, Singh V, Singh S, Chiranjivi A, Jakhar K, Sonar S, Tiwari M. et al. The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41. Int Immunopharmacol [Internet]. 2021. cited 2023 Dec 6. 101. 108187. Available from. https://pubmed.ncbi.nlm.nih.gov/34649114/.
   PubMed Web of Science ®Google Scholar
• Mishra N, Kumar S, Singh S, Bansal T, Jain N, Saluja S, Kumar R, Bhattacharyya S, Palanichamy JK, Mir RA. et al. Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma. PLOS Pathog [Internet] [ Available from]. 2021;17(9):e1009958. [cited 2023 Dec 6]. doi:10.1371/journal.ppat.1009958.
   PubMed Web of Science ®Google Scholar
• Lapidus S, Liu F, Casanovas-Massana A, Dai Y, Huck JD, Lucas C, Klein J, Filler RB, Strine MS, Sy M. et al. Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 spike protein. Sci Rep [Internet]. 2022;12(1): [cited 2023 Dec 6]. Available from. doi:10.1038/s41598-022-26709-7.
   Web of Science ®Google Scholar
• Bosaeed M, Alharbi NK. Vaccination strategies for mitigation of MERS-CoV outbreaks. Lancet Glob Heal [Internet]. 2023;11(5):e644–5 Available from.cited 2023 Dec 6. https://pubmed.ncbi.nlm.nih.gov/37061302/.
   PubMed Web of Science ®Google Scholar
• Bosaeed M, Balkhy HH, Almaziad S, Aljami HA, Alhatmi H, Alanazi H, Alahmadi M, Jawhary A, Alenazi MW, Almasoud A. et al. Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy middle eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial. The Lancet Microbe [Internet] [ Available from]. 2022;3(1):e11–20. [cited 2023 Dec 6]. doi:10.1016/S2666-5247(21)00193-2.
   PubMedGoogle Scholar
• Tai W, Zheng J, Zhang X, Shi J, Wang G, Guan X, Zhu J, Perlman S, Du L. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection. Virus Res [Internet]. 2023;334:199156. [cited 2023 Dec 6]. Available from. https://pubmed.ncbi.nlm.nih.gov/37336390/.
   PubMed Web of Science ®Google Scholar
• Tjärnhage E, Brown D, Bogen B, Andersen TK, Grødeland GG, Subbarao K. Trimeric, APC-Targeted subunit vaccines protect mice against seasonal and pandemic influenza. J Virol [Internet] Available from. 2023;97(2). [cited 2023 Dec 6]. doi:10.1128/jvi.01694-22.
   PubMed Web of Science ®Google Scholar
• Liu Y, Dai L, Feng X, Gao R, Zhang N, Wang B, Han J, Zou Q, Guo X, Zhu H. et al. Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA. Mol Biomed [internet]. 2021;2(1): [cited 2023 Dec 6]. Available from. doi:10.1186/s43556-021-00054-z.
   Google Scholar
• Chang CC, Algaissi A, Lai CC, Chang CK, Lin JS, Wang YS, Chang BH, Chang YC, Chen WT, Fan YQ. et al. Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus. Vaccine [ Available from]. 2023;41(21):3337–46. [cited 2023 Dec 6]. doi:10.1016/j.vaccine.2023.04.006.
   PubMed Web of Science ®Google Scholar
• Coutelier JP, JTM VDL, Heessen FWA, Warnier G, Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med [Internet]. 1987;165(1):64 Available from.cited 2023 Dec 8. https://pmc/articles/PMC2188250/?report=abstract.
   PubMed Web of Science ®Google Scholar
• Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, Bortolotti P, Martinez L, Dubucquoi S, Dessein R. et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS one [internet]. 2014;9(2):e88716. cited 2023 Dec 8. Available from. https://pmc/articles/PMC3925152/.
   PubMed Web of Science ®Google Scholar
• Alosaimi B, Hamed ME, Naeem A, Alsharef AA, AlQahtani SY, AlDosari KM, Alamri AA, Al-Eisa K, Khojah T, Assiri AM. et al. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine [Internet]. [ Available from]. 2020 [cited 2023 Dec 6];126:154895. doi:10.1016/j.cyto.2019.154895.
   Google Scholar
• Johnston SC, Johnson JC, Stonier SW, Lin KL, Kisalu NK, Hensley LE, Rimoin AW. Cytokine modulation correlates with severity of monkeypox disease in humans. J Clin Virol [Internet]. 2015;63:42–5. [cited 2023 Dec 6]. Available from. https://pubmed.ncbi.nlm.nih.gov/25600603/.
   PubMed Web of Science ®Google Scholar
• Dittmer U, Peterson KE, Messer R, Stromnes IM, Race B, Hasenkrug KJ. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to friend retrovirus infection. J Virol [Internet] Available from. 2001;75(2):654–60. [cited 2023 Dec 6]. doi:10.1128/JVI.75.2.654-660.2001.
   PubMed Web of Science ®Google Scholar